Free shipping on all orders over $ 500

TAS3681

Cat. No. M43901

All AbMole products are for research use only, cannot be used for human consumption.

TAS3681 Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

TAS3681 is an androgen receptor (AR) inhibitor that may be used in studies related to prostate cancer.

Chemical Information
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Shohei Yoshida, et al. Mol Oncol. TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer

[2] Navid Sobhani, et al. Int J Mol Sci. AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

Related Androgen Receptor Products
MDV3100

MDV3100 is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity.

Bicalutamide

Bicalutamide is an orally active non-steroidal androgen receptor antagonist (IC50 = 190 nM).

Ostarine

Ostarine (GTx-024 and MK-2866) is an investigational selective androgen receptor modulator (SARM) with Ki of 3.8 nM.

Andarine

Andarine (GTx-007, S-4) is a selective nonsteroidal androgen receptor (AR) agonist with Ki of 4 nM.

AZD3514

AZD3514 is a potent, orally activie and selective androgen receptor (AR) inhibitor with potential anticancer cancer activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: TAS3681 supplier, Androgen Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.